Literature DB >> 12105102

Neurokinin receptors modulate the neurochemical actions of cocaine.

P-A H Noailles1, J A Angulo.   

Abstract

The psychostimulant cocaine is an indirect agonist that increases synaptic dopamine (DA) by binding with high affinity to the DA transporter (DAT) and blocking the active transport of synaptic DA back into the terminal. The resulting increase in extracellular DA alters postsynaptic activity in the circuitry of the basal ganglia. This study examines the role of neurokinin receptors on cocaine-evoked DA overflow in the striatum. Male Sprague-Dawley rats (n = 8) were treated with cocaine (10 mg/kg body weight i.p.) acutely or chronically. The pattern of DA release was assessed using in vivo microdialysis. In separate experiments two different neurokinin-1 (NK-1) receptor antagonists (D-Arg(1), D-Pro(2), D-Trp(7,9), Leu(11), or L-733,060) were perfused via the microdialysis probe for one hour in awake and freely moving animals that were subsequently injected i.p. with cocaine. Throughout the procedure, DA release was monitored at 1/2-hour intervals at a flow rate of 1 microl/min. In the groups of rats preperfused with NK-1 antagonists into the striatum, the cocaine-evoked release of DA was significantly reduced. This result suggests a significant role for the NK-1 receptor in the striatal response to acute and chronic cocaine administration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105102     DOI: 10.1111/j.1749-6632.2002.tb04168.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  The role of the neurokinin-1 receptor in stress-induced reinstatement of alcohol and cocaine seeking.

Authors:  Jesse R Schank; Courtney E King; Hui Sun; Kejun Cheng; Kenner C Rice; Markus Heilig; David Weinshenker; Jason P Schroeder
Journal:  Neuropsychopharmacology       Date:  2013-10-31       Impact factor: 7.853

2.  Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.

Authors:  Padmanabhan Mannangatti; Santhanalakshmi Sundaramurthy; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  Psychopharmacology (Berl)       Date:  2016-12-24       Impact factor: 4.530

3.  Skin codelivery of contact sensitizers and neurokinin-1 receptor antagonists integrated in microneedle arrays suppresses allergic contact dermatitis.

Authors:  Mohna Bandyopadhyay; Adrian E Morelli; Stephen C Balmert; Nicole L Ward; Geza Erdos; Tina L Sumpter; Emrullah Korkmaz; Daniel H Kaplan; Martin H Oberbarnscheidt; Olga Tkacheva; William J Shufesky; Louis D Falo; Adriana T Larregina
Journal:  J Allergy Clin Immunol       Date:  2022-01-24       Impact factor: 14.290

4.  Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum.

Authors:  Jesus A Angulo; Nieves Angulo; Jing Yu
Journal:  Ann N Y Acad Sci       Date:  2004-10       Impact factor: 5.691

5.  Neuropeptidergic regulation of compulsive ethanol seeking in C. elegans.

Authors:  Chinnu Salim; Ann Ke Kan; Enkhzul Batsaikhan; E Clare Patterson; Changhoon Jee
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.